Pharmaceuticals
Pharmacosmos actively collaborates with global partners to bring best-in-class pharmaceuticals to patients. Discover the synergies in our partnership approach.
Pharmacosmos is a leader in the development and production of glucose poly- and oligosaccharides and their derivatives across a broad range of specifications. All of our products are manufactured at our factory in Denmark, which is GMP-approved to deliver products globally, including to the USA, the EU, China and Japan.
OUR OFFERING INCLUDES
The industry’s broadest range of standard, “off-the-shelf” products, covering a broad range of molecular weights and qualities – see www.dextran.com
An ability to swiftly produce carbohydrates according to customised specifications for our pharmaceutical customers. Examples include products with particular molecular weight distribution characteristics, extra low endotoxin content, etc.
Carbohydrate derivatives, both as standard products and as development support from early development to commercial scale. Our derivative synthesis facilities include a synthesis lab (gramme scale), a pilot plant (kg scale), and our full-scale CGMP-approved facilities (up to metric tonnes scale).
Visit www.dextran.com for further information or contact Anne-Marie Oerkild at dextran@pharmacosmos.com to explore specific opportunities.
PENTAHIBE®
For a number of years Pharmacosmos has worked on a carbohydrate-based cryoprotectant to achieve cryopreservation of cells without, or without dramatically reduced amounts of DMSO, without loss of efficacy. This has led to the development of our PentaHibe products, each containing the carbohydrate cryoprotectant pentaisomaltose, which have demonstrated effective cryopreservation for a number of cell types, including T cells, hematopoietic stem cells, cord blood and mesenchymal stem cells.
PentaHibe is commercially available in different formats, including a ready-to-use media, as well as a single component for companies wishing to develop an optimised media for their specific cell therapy applications. Pharmacosmos is also open to commercialisation partners for Pentaisomaltose®. For more information, visit www.pentahibe.com or contact us at dextran@pharmacosmos.com.
DEXTRAN
Pharmacosmos is a global leader in pharmaceutical quality dextrans, with a full range of products, including dextran products meeting the requirements of the US, European and Japanese pharmacopeias. Pharmacosmos furthermore offers pharmaceutical-quality ultra dextran (very narrow distributions), technical dextrans and molecular weight standards.
In our synthesis facility, we produce carbohydrate derivatives, including DEAE dextran, carboxymethyl dextran and amino dextran. For more information, visit www.dextran.com.
If you want to know how we can collaborate, please contact Anne-Marie Oerkild at dextran@pharmacosmos.com
COLLABORATION WITH RESEARCHERS & CLINICIANS
We collaborate with leading medical experts in driving research to uncover new clinical insights into iron metabolism and iron deficiency that have the potential to change the way iron deficiency is prevented and treated in humans. We are actively seeking opportunities to collaborate on investigator-sponsored studies.
To learn more, please contact Lars L. Thomsen at info@pharmacosmos.com
PHARMACOSMOS IST ...
Ein globaler Pionier in der Kohlenhydratchemie und ein führendes Unternehmen in der Entwicklung innovativer Behandlungen für Patienten, die an Eisenmangel und Eisenmangelanämie leiden.
